MMP2 and ovarian carcinoma: Higher MMP-2 concentrations were observed in the benign lesion (BL) group (median: 211.50 ng/mL) compared to the ovarian cancer (OC) group (median: 203.00 ng/mL, p = 0.12517), but this was not a statistically significant difference.